Cart
sales@molnova.com
AKR1C3-IN-1
CAS No. 327092-81-9
AKR1C3-IN-1( —— )
Catalog No. M20737 CAS No. 327092-81-9
AKR1C3-IN-1 is a potent and selective inhibitor of AKR1C3(IC50 of 13 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 46 | In Stock |
|
| 25MG | 83 | In Stock |
|
| 50MG | 147 | In Stock |
|
| 100MG | 239 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAKR1C3-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionAKR1C3-IN-1 is a potent and selective inhibitor of AKR1C3(IC50 of 13 nM).
-
DescriptionAKR1C3-IN-1 is a potent and selective inhibitor of AKR1C3(IC50 of 13 nM).
-
In VitroAKR1C3-IN-1 shows less potent activities with 20.3±3.8 μM against AKR1C1 and >30 μM against AKR1C2 and AKR1C4. AKR1C3-IN-1 inhibits AKR1C3 activity (inhibiting PR-104H formation) with an IC50 of 0.027±0.002 μM.
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetNADPH
-
RecptorAKR1C3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number327092-81-9
-
Formula Weight317.36
-
Molecular FormulaC16H15NO4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (315.10 mM)
-
SMILESOC(=O)c1cccc(c1)S(=O)(=O)N1CCc2ccccc2C1
-
Chemical Name3-(34-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jamieson S M F Brooke D G Heinrich D et al. 3-(34-Dihydroisoquinolin-2(1 H )-ylsulfonyl)benzoic Acids: Highly Potent and Selective Inhibitors of the Type 5 17-β-Hydroxysteroid Dehydrogenase AKR1C3[J]. Journal of Medicinal Chemistry 2012 55(17):7746-7758.
molnova catalog
related products
-
Nitrofurantoin
Nitrofurantoin is an antibiotic usually used to treat urinary tract infections.
-
Phloretic acid
Phloretic acid is a phenolic compound. It can be used to produce polyesters based on phloretic acid and gallic acid.
-
AKR1C3-IN-4
AKR1C3-IN-4 is a potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitor with an IC 50 of 0.56 μM. AKR1C3-IN-4 has the potential for castrate resistant prostate cancer (CRPC) research.
